Gregory A Dasch

Title: Innovations of Gregory A Dasch

Introduction

Gregory A Dasch is a notable inventor based in Stone Mountain, Georgia. He has made significant contributions to the field of medical research, particularly in the development of vaccines and diagnostic assays. With a total of six patents to his name, Dasch's work has had a profound impact on public health.

Latest Patents

One of his latest patents is focused on the truncated recombinant major outer membrane protein antigen (R56) of Orientia tsutsugamushi strains Karp, Kato, and Gilliam. This invention involves a recombinant, refolded non-fusion polypeptide expressed from a truncated R56 gene of the causative agent of scrub typhus. The invention is useful for detecting prior exposure to scrub typhus and for screening and identifying infectious strain similarities. It serves as a component in vaccine formulations and the production of immune globulins for passive prophylaxis and immunity in subjects.

Career Highlights

Gregory A Dasch works for the United States Navy, where he contributes his expertise in medical research and innovation. His role has allowed him to be at the forefront of developing solutions that address critical health challenges.

Collaborations

Dasch has collaborated with notable colleagues such as Wei-Mei Ching and Daryl J Kelly. These partnerships have enhanced the scope and impact of his research efforts.

Conclusion

Gregory A Dasch's contributions to medical research and innovation are commendable. His work continues to influence the development of effective diagnostic tools and vaccines, showcasing the importance of innovation in public health.